Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about elevated adverse effects which include drowsiness, although the clinical relevance is minimal in the majority of clients – observe the patient for adverse effects (e.The objective of this examine was to evaluate the